• Explore /
  • Poster
  • / Clinical outcomes and toxicity of estramustine phosphate (EP) addition to docetaxel (D) as first-line therapy for castration-resistant prostate cancer (CRPC): A cumulative analysis on 243 patients (pts) from two randomized phase II trials.

Clinical outcomes and toxicity of estramustine phosphate (EP) addition to docetaxel (D) as first-line therapy for castration-resistant prostate cancer (CRPC): A cumulative analysis on 243 patients (pts) from two randomized phase II trials.

Abstract Poster

Authors

null

Orazio Caffo

Medical Oncology Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Teodoro Sava , Fable Zustovich , Michele Lodde , Cosimo Sacco , Giovanni Lo Re , Sebastiano Buti , Umberto Basso , Teresa Gamucci , Gaetano Facchini , Alessandra Perin , Romana Segati , Lucianna Russo , Antonello Veccia , Enzo Galligioni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

2006-005728-17

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 208)

DOI

10.1200/jco.2013.31.6_suppl.208

Abstract #

208

Poster Bd #

C14

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

Poster

2023 ASCO Annual Meeting

Selection biases in the systematic collection of breast biobank specimens.

Selection biases in the systematic collection of breast biobank specimens.

First Author: Yael Bar

First Author: Adam J Olszewski

First Author: Giuseppe Lo Russo